Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
about
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent historyImpairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersDendritic and natural killer cells cooperate in the control/switch of innate immunityIncreased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug usersIkaros is required for plasmacytoid dendritic cell differentiation.Plasmacytoid dendritic cells in immunity.Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.Type I interferon dependence of plasmacytoid dendritic cell activation and migration.Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitisIn vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolatesImmediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts.Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.The role of type I interferon production by dendritic cells in host defense.Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria.Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cellsImpact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.Long-term pegylated interferon-alpha and its potential in the treatment of melanomaPlasmacytoid dendritic cells in antiviral immunity and autoimmunity.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics.Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon.Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.Flow cytometric analysis of natural interferon-alpha producing cells.Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.Determination of herpes simplex virus-induced alpha interferon-secreting human blood leucocytes by a filter immuno-plaque assay.Characterization of the blood mononuclear leucocytes producing alpha interferon after stimulation with herpes simplex virus in vitro, by means of combined immunohistochemical staining and in situ RNA-RNA hybridization.Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells.Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleenMouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
P2860
Q27485637-B3982D94-2973-47CD-BCE0-7586EE11F5DDQ33606519-AEC467E0-7DB9-4C04-B7F6-8E7240BE3B78Q33982102-67D38DFF-8BFD-4B2F-9FD0-9FEF456ABA67Q34517924-B4F4F3D5-B6BB-495F-909E-C10ED0AC7F68Q35660526-F2E0D10F-E0BF-4F16-8027-3106F316C197Q35848777-7006CBA2-23D6-41EE-B093-F4DA8A57E71BQ35953140-F7BA07FE-2C66-42DB-B59B-36DB46876B3BQ36361001-C882B664-8748-44DF-8CDB-2190F6599D0DQ36403406-ED435A69-B80D-479A-8943-29198A9A581EQ36637175-CC542A57-657C-4991-9EAC-1DA37A691B49Q36683771-BF32B879-FB4F-48C8-A8AB-8FFDACBE4CA6Q36694982-28F11E31-0341-4C98-9F44-F4788ED186ABQ36827554-E21004CE-F550-4908-B815-4C2AFC8FC64EQ36838232-E75D2552-077E-458D-A564-9EA05D0B76B2Q36996539-C19C94D1-E080-4508-A3F3-9D2352EEE6D1Q37189816-E9BFE618-D1D8-48B5-86D2-5B1AFE9EB68AQ37260482-8CA02A20-FCAF-4618-AA70-9D94BC6A28B9Q37384753-4F18660B-4BB0-4231-9F76-47B200B394BEQ37586916-EF46F900-C3D1-48A0-8554-4A8168A05C9EQ37769441-A10BDE98-0BA9-46DE-8018-7E39501A3119Q37854081-416359E2-D7F9-4249-B657-7AB3D26E0912Q37887500-9CE0F402-5D6E-4CD1-A6E8-2A3F0F0F447CQ40151408-F70F5843-BF0F-45BB-A1A4-D195C6C063B7Q40267906-EDC5FA10-96A0-4F2A-B6A9-C34798A3B5D6Q42767669-876F4147-889D-4579-8E17-F52EF6EFADC9Q44256949-9BF583A0-D8B8-445F-865B-CBBD2C6ED2A5Q45776604-9F59F511-3F71-457D-9E07-536D715C78ACQ45842023-1F72C4DC-3D30-4831-B8DF-B745A2A069CFQ45847213-BB5848F0-DA64-48C9-9936-0C5D2B737111Q52552996-E3611D80-FCCC-406B-AB31-0E649AC0B815Q56879737-5E85868D-4BA6-4BE0-B6CA-FBF2B452AA1BQ56987531-230CA75A-D9AD-4A6D-B450-78D8967EFF67
P2860
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@ast
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@en
type
label
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@ast
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@en
prefLabel
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@ast
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@en
P2093
P2860
P356
P1476
Requirement for HLA-DR+ access ...... alovirus-infected fibroblasts.
@en
P2093
B Perussia
D S Miller
G Trinchieri
S Bandyopadhyay
P2860
P304
P356
10.1084/JEM.164.1.180
P407
P577
1986-07-01T00:00:00Z